Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy

NCT06068439 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

355

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy Type 2

Interventions

DRUG: Acetylsalicylic Acid
DRUG: Placebo

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University